Galena Biopharma Announces Notice of Allowance of U.S. Patent Application for NeuVax(TM) (nelipepimut-S) Combination

Source :: GlobeNewswire. October 8, 2014
Publication Year :: 2014
Abstract: PORTLAND, Ore., Oct 08, 2014 (GLOBE NEWSWIRE via COMTEX) -- Galena Biopharma, Inc. (Nasdaq:GALE), a biopharmaceutical company developing and commercializing innovative, targeted oncology treatments that address major medical needs across [...]

Subjects :: Genentech Inc. -- Intellectual property
Biological products industry -- Intellectual property
Biotechnology industry -- Intellectual property
Sulfur compounds
Patents
Patent/copyright issue
Banking, finance and accounting industries
Business
Herceptin (Medication)

Tools